Flourish Research - San Antonio

Type 2 Diabetic on Ozempic or Mounjaro

Qualified participants must:

Basic Criteria 

  • Are you 18+
  • Diagnosed with Type 2 Diabetes 
  • Currently on name brand Mounjaro or Ozempic as only treatment for T2D for past 5 months, allowing for temporary disruption of up to 2 weeks. 
  • Must be able to bring in medical records that:
    • year diagnosed with diabetes
    • start date of Ozempic or Mounjaro
    • additional diabetes medications if applicable
    • most recent A1c, A1c prior to start Ozempic or Mounjaro
    • and weight prior to starting Ozempic or Mounjaro if known (if unknown, this is ok).
    • show Mounjaro or Ozempic dates of use 

 

Answers Must Be NO 

  • Are you pregnant? 
  • Do you have a cognitive impairment, hearing difficulty, visual impairment, severe psychopathology, or insufficient knowledge of English that would make you unable to complete the study visit and questionnaires 
  • Are you currently on any medications intended for chronic weight management (including but not limited to Zepbound and Wegovy)? 
  • Are you diagnosed with type 1 diabetes?
  • Are you on a GLP-1 receptor agonist other than Ozempic.  Examples include Trulicity, Bydureon, Victoza, and Rybelsus.   
  • Have you been in another study with investigational product in the last 30 days?  

 

Answers Must be Yes 

  • Are you able to read and understand study directions? 
  • If you have access to it, can you bring in your last recorded A1c reading for your visit? (OK, if they don’t have it but preferred) (examples: lab printout or access to it on their phone so they can share during visit and can be printed) 

 

 

 

 

Compensation up to $100 may be available for time and travel. 

 

Insurance is not required.

 

If you do not see an available appointment, please call 210-714-0067 for availability.

 

Transportation may be available. Call 210-714-0067.

Schedule Appointment
Flourish Research News

Stay current with the latest clinical trial news and learn how Flourish Research is supporting the advancement of life-changing therapeutics.

Exciting News! ENCORE™ is now part of the Flourish family!